Journal Information
Vol. 46. Issue S3.
X Eurasian Hematology Oncology Congress
Pages 5 (May 2024)
Vol. 46. Issue S3.
X Eurasian Hematology Oncology Congress
Pages 5 (May 2024)
Adult Hematology Abstract Categories, LymphomaOP 06
Full text access
AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN PATIENTS WITH HIV-ASSOCIATED LYMPHOPROLYPHERATIVE DISORDER
Visits
720
Vera Kovalskaya, Natalya Falaleeva, Stanislav Shklyaev, Andrey Chelmakov, Ludmila Grivtsova
A. Tsyb Medical Radiological Research Centre - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Obninsk, Russian Federation
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 46. Issue S3

X Eurasian Hematology Oncology Congress

More info
Objective

Autologous transplantation of bone marrow/peripheral blood stem cells in patients with HIV-associated lymphopoliferative disorder is a feasible and relatively safe therapeutic option. However, at the moment there are a number of unsolved problems, including optimal risk/benefit pre-transplant conditioning, taking into account drug-drug interactions and indications for hematopoietic stem cell transplantation.

Methodology

Since 2020 PBSCT has been performed in 15 patients with HIV in our center. The 12 (80%), had diagnosis of HIV-associated plasmablastic lymphoma (HIV-PBL), 3 patients (20%) were with HIV-associated Hodgkin' lymphoma (HIV-HL). All of the patients with HIV-PBL were transplanted after completion of a first-line treatment and achievement of at least a partial response. The pre-transplant conditioning was performed using BEAM-like regimens.

Results

Toxicity from organs and systems did not exceed grade 2 (moderate) mainly from the gastrointestinal tract, no need antiretroviral therapy in all of the cases. Median time to neutrophil engraftment was +12 days, while to platelet engraftment was +13 days. At the time of submitting the abstract all of the transplanted patients described above except one (lethal case due to progression of concomitants hepatitis C virus (HCV) infection) are in the state of remission.

Conclusion

Autologous transplantation of peripheral blood stem cells in patients with HIV is a feasible and relatively safe option with clear planning of the patient's treatment strategy from the first day of therapy and accompanying consideration of drug-drug interactions which is confirmed both by world literature and our Center's own experience.

Full text is only available in PDF
Download PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools